These covariates included demographics (age, gender [male, female, unknown], race [Black or African American, White, Asian], ethnicity [Hispanic or Latino, Not Hispanic or Latino, unknown], and marital status), socioeconomic determinants of health (SDOHs) including education, employment, environmental exposure, and housing, problems related to lifestyle, cancer, diabetes severity indicators (e.g., obesity, complications like nephropathy, liver, neuropathy, heart disease), some conditions known to be associated with constipation or intestinal obstruction (e.g., diseases of intestines, diseases of appendix), and prior prescription of medicines associated with diabetes, decreased intestinal motility, or constipation [15, 16, 27,28,29,30]
June 2, 2025: Study Shows Wegovy Is Not the Top GLP-1 Weight-Loss Drug Research funded by Eli Lilly found that Zepbound outperformed Wegovy in helping people lose weight over a 72-week period
Youve likely seen the conflicting headlines and wondered if the life-changing weight loss youre experiencing is truly sustainable
And its more easily absorbed than other glutathione due to the fermentation process initially used to create it